Overview

• Wegovy, a popular weight loss drug, now also approved in the U.S. for reducing serious cardiovascular risks in obese adults.
• Despite its new health benefits, insurance coverage for Wegovy remains uncertain, with many employers and health plans wary of its high cost.
• State Medicaid programs are required to cover Wegovy for its new use, but weight loss treatments can be excluded, leading to a patchwork of coverage.
• North Carolina plans to drop coverage for GLP-1s used for weight loss, including Wegovy, due to financial constraints.
• The Centers for Medicare and Medicaid ServicesFDA's expanded approval of Wegovy, potentially leading to Medicare coverage.